Are BTK and PLCG2 mutations required and adequate for ibrutinib resistance in chronic lymphocytic leukemia? Chronic lymphocytic leukemia can be a perfectly-defined lymphoid neoplasm with quite heterogeneous Organic and medical habits. The last ten years continues to be remarkably fruitful in novel results elucidating numerous areas of the pathogenesis of https://abigaile186vdl2.theideasblog.com/profile